Aligos Therapeutics Inc
ALGS7.840USD
+0.380+5.09%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
54.21MMarket Cap
LossP/E TTM
Aligos Therapeutics Inc
7.840
+0.380+5.09%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
-68.46%311.00K
-76.54%629.00K
-60.82%1.27M
-84.59%1.06M
-63.79%986.00K
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
863.76%3.54M
167.14%4.11M
139.03%3.69M
182.53%2.57M
--367.00K
--1.54M
--1.54M
--910.00K
----
----
--0.00
--0.00
Revenue
-68.46%311.00K
-76.54%629.00K
-60.82%1.27M
-84.59%1.06M
-63.79%986.00K
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
863.76%3.54M
167.14%4.11M
139.03%3.69M
182.53%2.57M
--367.00K
--1.54M
--1.54M
--910.00K
----
----
--0.00
--0.00
Operating expenses
-15.10%19.55M
-40.95%16.99M
-3.65%21.40M
19.32%27.48M
-0.47%23.03M
9.76%28.78M
-3.66%22.21M
-4.40%23.03M
-39.31%23.14M
-31.57%26.22M
-33.38%23.05M
-22.58%24.09M
33.08%38.13M
11.75%38.31M
60.53%34.60M
46.26%31.11M
38.27%28.65M
--34.29M
--21.56M
--21.27M
--20.72M
R&D expenses
-11.39%14.50M
-27.97%16.03M
5.72%16.77M
25.73%21.10M
-9.75%16.37M
16.53%22.26M
-10.81%15.87M
1.64%16.78M
-42.75%18.14M
-33.21%19.10M
-36.76%17.79M
-32.76%16.51M
38.51%31.68M
1.84%28.60M
67.39%28.13M
42.96%24.55M
32.18%22.87M
--28.08M
--16.81M
--17.18M
--17.30M
Depreciation, depletion, and amortization
-33.33%200.00K
-38.83%241.00K
-2.28%300.00K
-25.74%300.00K
-33.92%300.00K
-24.52%394.00K
-42.94%307.00K
-32.67%404.00K
-32.84%454.00K
-28.30%522.00K
-31.29%538.00K
-22.08%600.00K
-8.77%676.00K
-0.27%728.00K
10.59%783.00K
-19.71%770.00K
112.93%741.00K
--730.00K
--708.00K
--959.00K
--348.00K
Operating profit
12.71%-19.24M
37.30%-16.36M
-6.11%-20.13M
-63.65%-26.41M
-7.97%-22.05M
-15.06%-26.10M
-0.12%-18.97M
20.85%-16.14M
42.58%-20.42M
40.23%-22.68M
42.70%-18.95M
31.02%-20.39M
-28.18%-35.56M
-10.68%-37.95M
-53.40%-33.07M
-38.99%-29.57M
-33.87%-27.74M
---34.29M
---21.56M
---21.27M
---20.72M
Net non-operating interest income (expenses)
Non-operating interest income
45.17%842.00K
-80.24%314.00K
-54.53%457.00K
-66.60%319.00K
-22.46%580.00K
109.91%1.59M
115.67%1.00M
350.47%955.00K
769.77%748.00K
1582.22%757.00K
2230.00%466.00K
190.41%212.00K
-18.10%86.00K
-83.39%45.00K
-91.45%20.00K
-80.48%73.00K
-77.56%105.00K
--271.00K
--234.00K
--374.00K
--468.00K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.00K
----
----
----
----
----
----
----
Special income (expenses)
--61.49M
-50432.00%-50.33M
----
----
----
--100.00K
---100.00K
---3.00M
---3.50M
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
100.28%38.00K
-347.98%-15.74M
837.04%506.00K
20521.71%31.34M
-5364.96%-13.37M
-4093.18%-3.51M
129.67%54.00K
-50.00%152.00K
379.12%254.00K
-33.33%88.00K
-464.00%-182.00K
202.01%304.00K
-1616.67%-91.00K
170.97%132.00K
100.42%50.00K
-826.83%-298.00K
-97.32%6.00K
---186.00K
---11.97M
--41.00K
--224.00K
Income before tax
223.80%43.13M
-194.12%-82.12M
-6.42%-19.17M
129.11%5.25M
-52.03%-34.84M
-27.87%-27.92M
3.49%-18.01M
9.27%-18.03M
35.56%-22.92M
42.19%-21.84M
43.44%-18.66M
33.28%-19.88M
-28.71%-35.56M
-10.44%-37.77M
0.90%-33.00M
-42.84%-29.79M
-37.94%-27.63M
---34.20M
---33.30M
---20.86M
---20.03M
Income tax
79.17%43.00K
190.00%27.00K
213.79%91.00K
-75.03%189.00K
-38.46%24.00K
-161.22%-30.00K
167.44%29.00K
1510.64%757.00K
-26.42%39.00K
184.48%49.00K
-134.13%-43.00K
67.86%47.00K
17.78%53.00K
-126.48%-58.00K
--126.00K
147.46%28.00K
--45.00K
--219.00K
--0.00
---59.00K
--0.00
Income after tax
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Net income from continuous operations
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Net income attributable to controlling interests
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Net income attributable to common shareholders
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Basic earnings per share
191.81%5.12
-20.51%-13.08
70.39%-3.07
107.44%0.81
58.27%-5.58
15.04%-10.85
4.75%-10.37
6.89%-10.87
36.14%-13.37
43.15%-12.77
44.26%-10.89
40.89%-11.67
-13.32%-20.94
4.43%-22.47
13.45%-19.53
-40.13%-19.75
-36.16%-18.48
---23.51
---22.57
---14.09
---13.57
Diluted earnings per share
62.14%-2.11
-20.51%-13.08
70.39%-3.07
107.43%0.81
58.27%-5.58
15.04%-10.85
4.75%-10.37
6.89%-10.87
36.14%-13.37
43.15%-12.77
44.26%-10.89
40.89%-11.67
-13.32%-20.94
4.43%-22.47
13.45%-19.53
-40.13%-19.75
-36.16%-18.48
---23.51
---22.57
---14.09
---13.57
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
